Cargando…
LKB1IP promotes pathological cardiac hypertrophy by targeting PTEN/Akt signalling pathway
Pathological cardiac hypertrophy represents a leading cause of morbidity and mortality worldwide. Liver kinase B1 interacting protein 1 (LKB1IP) was identified as the binding protein of tumour suppressor LKB1. However, the role of LKB1IP in the development of pathological cardiac hypertrophy has not...
Autores principales: | Tian, Mi, Jiang, Xiuxin, Li, Xinyun, Yang, Jianmin, Zhang, Cheng, Zhang, Wencheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933949/ https://www.ncbi.nlm.nih.gov/pubmed/33486894 http://dx.doi.org/10.1111/jcmm.16199 |
Ejemplares similares
-
Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
por: Aiyasiding, Xiahenazi, et al.
Publicado: (2022) -
Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway
por: Yang, Hui, et al.
Publicado: (2020) -
Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR signal pathways
por: Chen, Yan, et al.
Publicado: (2022) -
Hepatic HuR protects against the pathogenesis of non-alcoholic fatty liver disease by targeting PTEN
por: Tian, Mi, et al.
Publicado: (2021) -
Long non‐coding RNA cardiac hypertrophy‐associated regulator governs cardiac hypertrophy via regulating miR‐20b and the downstream PTEN/AKT pathway
por: Zhang, Mingyu, et al.
Publicado: (2019)